DRM reports receiving research support from Janssen, serving on advisory boards and as a consultant for Novo Nordisk, Novartis, Eli Lilly, Sanofi-Aventis, Janssen and Servier, and giving lectures for Novo Nordisk, Servier, Sanofi-Aventis, Eli Lilly, Novartis and Janssen
This is a more limited application than what many peptide researchers use GHK-Cu for
However, two factors could drive increased supply, and possible increases in demand
Featured Advantages of Hi-Affi GLP1R Stable Cell Lines Besides GLP1R, Creative Biolabs now offers a full portfolio of Hi-Affi GPCR stable cell lines engineered with cAMP-activated biosensors, including but not limited to: Aiming at providing most reliable and custom-oriented services to assist our customers projects